Congratulations to Dr. Rebecca Deyell, her project, “Impact of Body Composition and Pharmacogenomics on Toxicity and Survival Outcomes in Childhood Bone Sarcoma,” received a 100% Fund Grant Award from C17 Children’s Cancer & Blood Disorders in the 2023/2024 competition.
C17, is an organization composed of the institutionally appointed heads of the sixteen pediatric hematology, oncology, and stem cell transplant programs across Canada and represents the interests of children and adolescents with cancer and blood disorders and acts as an authoritative Canadian voice.
C17, has a strong record of accomplishment and has developed a clear strategy for continuing its mission to improve health outcomes and quality of life for children and adolescents in Canada with cancer and blood disorders.
More:
https://bcchr.ca/rdeyell